Creative Medical Technology Files to Offer 3.05M Shares, 6.09M Warrants, Signaling Major Dilution
Summary
Creative Medical Technology Holdings filed to offer up to 3.05 million shares and 6.09 million warrants. This follows an S-1 registration statement filed earlier today for a public offering. The potential share issuance alone represents over 60% dilution based on the company's implied current share count. This capital raise is critical for the company, which reported zero revenue and a $1.48 million cash decrease in Q1 2026, but it comes at a significant cost to existing shareholders. The pricing and final terms of the offering will be crucial to watch.
At the time of this announcement, CELZ was trading at $1.52 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.4M. The 52-week trading range was $1.50 to $6.25. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.